RT Journal Article
SR Electronic
T1 Correction: Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000891corr1
DO 10.1136/jitc-2020-000891corr1
VO 9
IS 5
YR 2021
UL http://jitc.bmj.com/content/9/5/e000891corr1.abstract